Early cannulation arteriovenous graft (Acuseal) versus standard arteriovenous graft in patients with end-stage renal disease
| Autor: | Zelong Liu, Qianwen Zeng, Jinyun He, Lijuan Zeng, Fen Lang, Min Yang, Ruiming Liang, Qing Tang, Shuwen Wu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Time Factors medicine.medical_treatment 030232 urology & nephrology 030204 cardiovascular system & hematology Single Center Prosthesis Design End stage renal disease Catheterization 03 medical and health sciences Blood Vessel Prosthesis Implantation 0302 clinical medicine Arteriovenous Shunt Surgical Interquartile range Renal Dialysis medicine Humans Vascular Patency Retrospective Studies business.industry Graft Occlusion Vascular Hematology Perioperative Middle Aged medicine.disease Thrombosis Surgery Blood Vessel Prosthesis Exact test Treatment Outcome Nephrology Kidney Failure Chronic Female Hemodialysis business Complication |
| Zdroj: | Hemodialysis international. International Symposium on Home HemodialysisREFERENCES. 25(4) |
| ISSN: | 1542-4758 |
| Popis: | INTRODUCTION The use of Acuseal arteriovenous graft (AAVG) is spreading in end-stage renal disease (ESRD) patients for its advantages in early cannulation. However, comparison of clinical outcomes between AAVGs and standard arteriovenous grafts (SAVGs) is limited. In this study, we compared the performance of AAVGs and SAVGs. METHODS Consecutive ESRD patients underwent prosthetic vascular access between October 2017 and May 2019 at a single center were identified. Patients were divided into AAVG group and SAVG group. Patients' demographics, perioperative characteristics, and clinical outcomes were collected. Primary, primary assisted, and secondary patency rates were compared using Kaplan-Meier analyses. Postsurgery complications were compared using chi-square test or the Fisher's exact test. FINDINGS A total of 304 arteriovenous grafts (AVGs) were implanted in 145 males and 159 females (mean age, 60.1 years; range, 20-91 years), comprising 143 AAVGs and 161 SAVGs. Median time to first cannulation was 3 days (interquartile range [IQR], 1-15 days) in the AAVG group and 30 days (IQR, 20-52 days) in the SAVG group (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text